Interaction between cannabinoid CB 1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum

British Journal of Pharmacology

Volumn 158, Issue 1, 2009, Pages 243-251

  Baldassano, S ^a   Zizzo, Maria Grazia ^a   Serio, R ^a   Mule F ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

ATP; Cannabinoids; CB 1 receptors; Cholinergic transmission; Enteric nervous system; P2X receptors; Purines

Indexed keywords

8,8' [CARBONYLBIS(IMINO 4,1 PHENYLENECARBONYLIMINO 4,1 PHENYLENECARBONYLIMINO) BIS(1,3,5 NAPHTHALENETRISULFONIC ACID)]; ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ATROPINE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; N (2 CHLOROETHYL) 5,8,11,14 EICOSAETRAENAMIDE; NAPHTHALENESULFONIC ACID DERIVATIVE; PURINERGIC P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZO(BENZENE 2,4 DISULFONIC ACID); TETRODOTOXIN; THEOPHYLLINE; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL 2 CHLOROETHYLAMIDE; ARACHIDONYL-2-CHLOROETHYLAMIDE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; DRUG ANTAGONISM; ILEUM; INTESTINE CONTRACTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOMECHANICS; C57BL MOUSE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GASTROINTESTINAL MOTILITY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARACHIDONIC ACIDS; BIOMECHANICS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL MOTILITY; ILEUM; MALE; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTOR, CANNABINOID, CB1;

EID: 69249214024     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00260.x     Document Type: Article

References (52)

1. Abbracchio MP, Burnstock G (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64 : 445 475.
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
3. 1 receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle. Eur J Pharmacol 582 : 132 138.
4. Begg M, Dale N, Llaudet E, Molleman A, Parson ME (2002a). Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum. Br J Pharmacol 137 : 1298 1304.
5. Begg M, Molleman A, Parson M (2002b). Modulation of the release of endogenous γ-aminobutyric acid by cannabinoids in the guinea-pig ileum. Eur J Pharmacol 434 : 87 94.
6. 3 subunit. J Physiol 551 : 309 322.
7. Bornstein JC (2008). Purinergic mechanisms in the control of gastrointestinal motility. Purinergic Signal 4 : 497 212.
8. Burnstock G (2007). Purine and pyrimidine receptors. Cell Mol Life Sci 64 : 1471 1483.
9. 1 receptors. Br J Pharmacol 155 : 681 689.
10. 1 and opioid receptors in gastrointestinal motilità in mice. Br J Pharmacol 148 : 1043 1050.
11. Casu MA, Porcella A, Ruiu S, Saba P, Marchese G, Carai MA et al. (2003). Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459 : 97 105.
12. Colombo G, Agabio R, Lobina C, Reali R, Gessa GL (1998). Cannabinoid modulation of intestinal propulsion in mice. Eur J Pharmacol 344 : 67 69.
13. Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M et al. (2003). The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112 : 423 431.
14. Coutts AA, Pertwee RG (1997). Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 121 : 1557 1566.
15. Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP et al. (1998). In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125 : 1393 1395.
16. Cunha AR, Ribeiro JA (2000). ATP as a presynaptic modulator. Life Sci 68 : 119 137.
17. Damer S, Niebel B, Czeche S, Nickel P, Ardanuy U, Schmalzing G et al. (1998). NF279: a novel potent and selective antagonist of P2X receptor-mediated responses. Eur J Pharmacol 350 : R5 R6.
18. De Man JG, De Winter BY, Seerdeen TC, De Schepper U, Herman AG, Pelckamans PA (2003a). Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved. Br J Pharmacol 140 : 1108 1116.
19. De Man JG, Seerdeen TC, De Winter BY, Van Marck EA, Herman AG, Pelckamans PA (2003b). Alteration of the purinergic modulation of the enteric neurotransmission in the mouse ileum during chronic intestinal inflammation. Br J Pharmacol 139 : 172 184.
20. De Petrocellis L, Cascio MG, Di Marzo V (2004). The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141 : 765 774.
21. Galligan JJ (2002). Pharmacology of synaptic transmission in the enteric nervous system. Curr Opin Pharmacol 2 : 623 629.
22. Giaroni C, Knight GE, Ruan HZ, Glass R, Bardini M, Lecchini S et al. (2002). P2 receptors in the murine gastrointestinal tract. Neuropharmacology 43 : 1313 1323.
23. Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I et al. (2002). A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22 : 9612 9617.
24. Izzo AA, Coutts AA (2005). Cannabinoids and the digestive tract. Handb Exp Pharmacol 168 : 573 598.
25. Izzo AA, Mascolo N, Borrelli F, Capasso F (1998). Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid 1 receptors. Br J Pharmacol 124 : 1363 1368.
26. 1 receptors. Naunyn Schmiedebergs Arch Pharmacol 359 : 65 70.
27. 1-receptor mediated regulation of gastrointestinal motility in mice n a model of intestinal inflammation. Br J Pharmacol 134 : 563 570.
28. Kadowaki M, Takeda M, Tokita K, Hanaoka K, Tomoi M (2000). Molecular identification and pharmacological characterization of adenosine receptors in the guinea-pig colon. Br J Pharmacol 129 : 871 876.
29. Klapperstuck M, Buttner C, Nickel P, Schmalzing G, Lambrecht G, Markwardt F (2000). Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors. Eur J Pharmacol 387 : 245 252.
30. Krishtal O, Lozovaya N, Fedorenko A, Savelyew I, Chizhmakov I (2006). The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids. Pflugers Arch 453 : 353 360.
31. Lee JJ, Talubmook C, Parsons ME (2001). Activation of presynaptic A1-receptors by endogenous adenosine inhibits acetylcholine release in the guinea-pig ileum. J Auton Pharmacol 21 : 29 38.
32. Lòpez-Redondo F, Less GM, Pertwee RG (1997). Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br J Pharmacol 122 : 330 334.
33. MacNaughton WK, Van Sickle MD, Keenan CM, Cushing K, Mackie K, Sharkey KA (2004). Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves. Am J Physiol 286 : G863 G871.
34. Massa F, Monory K (2006). Endocannabinoids and the gastrointestinal tract. J Endocrinol Invest 29 : 47 57.
35. Massa F, Storr M, Lutz B (2005). The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med 83 : 944 954.
36. Mulè F, Naccari D, Serio R (2005). Evidence for the presence of P2y and P2x receptors with different functions in mouse stomach. Eur J Pharmacol 513 : 135 140.
37. Mulè F, Amato A, Baldassano S, Serio R (2007a). Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. Pharmacol Res 56 : 132 139.
38. Mulè F, Amato A, Baldassano S, Serio R (2007b). Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Pharmacol Res 56 : 185 192.
39. North RA (2002). Molecular physiology of P2X receptors. Physiol Rev 82 : 1013 1067.
40. Pinto L, Izzo AA, Cascio MG, Bisogno T, Hospodar-Scott K, Brown DR et al. (2002). Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 123 : 227 234.
41. Ralevic V, Burnstock G (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50 : 413 492.
42. Rettinger J, Schmalzing G, Damer S, Muller G, Nickel P, Lambrecht G (2000). The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor. Neuropharmacology 39 : 2044 2053.
43. Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H (2003). Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170 : 4953 4962.
44. Sawynok J, Jhamandasn KH (1976). Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J Pharmacol Exp Ther 197 : 379 390.
45. Serio R, Alessandro M, Zizzo MG, Tamburello MP, Mulè F (2003). Neurotransmitters involved in the fast inhibitory junction potentials in mouse distal colon. Eur J Pharmacol 460 : 183 190.
46. Storr M, Sibaev A, Marsicano G, Lutz B, Schusdziarra V, Timmermans J-P et al. (2004). Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. Am J Physiol 286 : G110 G117.
47. 2X1 receptors in mouse ileum, bladder and reproductive systems. Auton Neurosci 92 : 56 64.
48. Vizi ES, Knoll J (1976). The inhibitory effect of adenosine and related nucleotides on the release of acethylcholine. Neuroscience 1 : 391 398.
49. 3 receptors mediate the adenosine-induced relaxation in spontaneously active possum duodenum in vitro. Br J Pharmacol 138 : 1333 1339.
50. Wright K, Rooney N, Feeney M, Tate J, Robertson D, Welham M et al. (2005). Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129 : 437 453.
51. Yuece B, Sibaev A, Broedl UC, Morsicano G, Göke B, Lutz B et al. (2007). Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex. Neurogastroenterol Motil 19 : 744 753.
52. Zizzo MG, Mulè F, Serio R (2006). Inhibitory responses to exogenous adenosine in murine proximal and distal colon. Br J Pharmacol 148 : 956 963.